Quick facts
Approved in 35+ Countries
Phase 3 Complete
What is Thymosin Alpha 1?
Thymosin alpha 1 is a synthetic version of a protein naturally produced by the thymus gland, which is the master training center for the immune system. It acts as an immune modulator, meaning it helps balance the immune system. Researchers are studying how it might boost immune response when fighting infections or calm the immune system down when it is overactive.
Common Uses
In clinical research, thymosin alpha 1 was associated with balancing immune responses, supporting both underactive and overactive immune systems.
Clinical trials have studied thymosin alpha 1 as an adjunct therapy to support the immune system’s response to viral infections like hepatitis B and C.
Research suggests thymosin alpha 1 may enhance the body’s immune response to certain vaccines, particularly in older adults or immunocompromised individuals.
In research, thymosin alpha 1 was associated with modulating immune activity in certain autoimmune conditions.
Thymosin alpha 1 is a synthetic version of a natural immune protein. In research, thymosin alpha 1 was associated with regulating immune function, helping the body respond to infections while preventing overactive immune responses.
Thymosin alpha 1 is approved as a prescription medication in over 35 countries, though it is not FDA-approved in the US. It was generally well-tolerated in clinical trials, with mild injection site reactions being the most common side effect. A licensed provider should be consulted before use.
In clinical trials, immune modulation with thymosin alpha 1 was typically observed over several weeks to months of treatment, depending on the condition being studied. Individual results vary.
Yes. Thymosin alpha 1 is not FDA-approved in the US. A licensed healthcare provider should review your health history before you consider tghymosin alpha 1 peptide therapy.
Have a question you don’t see answered?
Ready to take the next step?
Find a verified peptide therapy provider or list your practice and connect with patients actively seeking trusted care.